TCG Opportunity III GP, LLC insider trades: Eikon Therapeutics (EIKN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where TCG Opportunity III GP, LLC reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | EIKN | ↑ Buy | 89,200 | $11.56 | $1.0M | Indirect | Sep 8, 2026 (5d) |
| Feb 25, 2026 | TNYA | ↓ Sell | 4,170,266 | $0.57 | $2.4M | Indirect | Feb 26, 2026 (1d) |
| Feb 23, 2026 | TNYA | ↓ Sell | 829,734 | $0.61 | $505K | Indirect | Feb 24, 2026 (1d) |
| Feb 11, 2026 | TNYA | ↓ Sell | 4,400,290 | $0.69 | $3.0M | Indirect | Feb 12, 2026 (1d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 1,437,323 | $18.00 | $25.9M | By The Column Group IV, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 630,881 | $18.00 | $11.4M | By The Column Group Opportunity III, LP | Feb 9, 2026 (3d) |
| Feb 6, 2026 | EIKN | ↑ Buy | 49,556 | $18.00 | $892K | By The Column Group IV-A, LP | Feb 9, 2026 (3d) |
| Jan 20, 2026 | SRZN | ↑ Buy | 17,229 | $19.74 | $340K | By The Column Group III-A, LP | Jan 20, 2026 (0d) |
| Jan 20, 2026 | SRZN | ↑ Buy | 15,278 | $19.74 | $302K | By The Column Group III, LP | Jan 20, 2026 (0d) |
| Jan 14, 2026 | SRZN | ↑ Buy | 9,536 | $19.86 | $189K | By The Column Group III-A, LP | Jan 15, 2026 (1d) |
| Jan 14, 2026 | SRZN | ↑ Buy | 8,457 | $19.86 | $168K | By The Column Group III, LP | Jan 15, 2026 (1d) |
| Jan 6, 2026 | SRZN | ↑ Buy | 8,003 | $19.89 | $159K | By The Column Group III-A, LP | Jan 8, 2026 (2d) |
| Jan 6, 2026 | SRZN | ↑ Buy | 7,097 | $19.89 | $141K | By The Column Group III, LP | Jan 8, 2026 (2d) |
| Dec 5, 2025 | SRZN | ↑ Buy | 19,172 | $19.22 | $369K | By The Column Group III-A, LP | Dec 8, 2025 (3d) |
| Dec 5, 2025 | SRZN | ↑ Buy | 16,978 | $19.22 | $326K | By The Column Group III, LP | Dec 8, 2025 (3d) |
| Nov 13, 2025 | SRZN | ↑ Buy | 167,307 | $12.65 | $2.1M | By The Column Group III-A, LP | Nov 17, 2025 (4d) |
| Nov 13, 2025 | SRZN | ↑ Buy | 148,150 | $12.65 | $1.9M | By The Column Group III, LP | Nov 17, 2025 (4d) |
| Mar 26, 2025 | SRZN | ↑ Buy | 365,769 | $11.60 | $4.2M | By The Column Group III-A, LP | Mar 28, 2025 (2d) |
| Mar 26, 2025 | SRZN | ↑ Buy | 344,827 | $11.60 | $4.0M | By The Column Group Opportunity III, LP | Mar 28, 2025 (2d) |
| Mar 26, 2025 | SRZN | ↑ Buy | 323,886 | $11.60 | $3.8M | By The Column Group III, LP | Mar 28, 2025 (2d) |
| Mar 5, 2025 | TNYA | ↑ Buy | 35,714,284 | $0.70 | $25.0M | Indirect | Mar 7, 2025 (2d) |
| Feb 12, 2024 | TNYA | ↑ Buy | 2,222,222 | $4.50 | $10.0M | Indirect | Feb 14, 2024 (2d) |
| Nov 16, 2023 | NGM | ↑ Buy | 22,631 | $0.69 | $16K | Indirect | Nov 17, 2023 (1d) |
| Mar 10, 2023 | TNYA | ↑ Buy | 6,779 | $2.60 | $18K | Indirect | Mar 14, 2023 (4d) |
| Feb 8, 2023 | TNYA | ↑ Buy | 1,500,000 | $2.60 | $3.9M | Indirect | Feb 10, 2023 (2d) |
| Jan 31, 2023 | NGM | ↑ Buy | 184,272 | $5.00 | $921K | Indirect | Feb 1, 2023 (1d) |
| Jan 23, 2023 | NGM | ↑ Buy | 9,900 | $5.00 | $49K | Indirect | Jan 25, 2023 (2d) |
| Jan 20, 2023 | NGM | ↑ Buy | 38,139 | $5.00 | $191K | Indirect | Jan 23, 2023 (3d) |
| Jan 19, 2023 | TNYA | ↑ Buy | 69,739 | $2.50 | $174K | Indirect | Jan 23, 2023 (4d) |
| Jan 18, 2023 | TNYA | ↑ Buy | 185,151 | $2.51 | $465K | Indirect | Jan 19, 2023 (1d) |
| Jan 12, 2023 | NGM | ↑ Buy | 5,378 | $4.95 | $27K | Indirect | Jan 17, 2023 (5d) |
| Jan 11, 2023 | NGM | ↑ Buy | 309,070 | $4.79 | $1.5M | Indirect | Jan 12, 2023 (1d) |
| Dec 12, 2022 | NGM | ↑ Buy | 300 | $4.98 | $1K | Indirect | Dec 14, 2022 (2d) |
| Nov 22, 2022 | NGM | ↑ Buy | 40,327 | $5.00 | $202K | Indirect | Nov 23, 2022 (1d) |
| Nov 21, 2022 | TNYA | ↑ Buy | 9,615,384 | $2.60 | $25.0M | Indirect | Nov 23, 2022 (2d) |
| Nov 4, 2022 | NGM | ↑ Buy | 139,148 | $4.92 | $684K | Indirect | Nov 7, 2022 (3d) |
| Oct 27, 2022 | NGM | ↑ Buy | 76,877 | $4.86 | $374K | Indirect | Oct 31, 2022 (4d) |
| Oct 26, 2022 | NGM | ↑ Buy | 123,820 | $4.81 | $595K | Indirect | Oct 27, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About TCG Opportunity III GP, LLC's insider trades
TCG Opportunity III GP, LLC is an insider at Eikon Therapeutics (EIKN). Since Oct 26, 2022, it has reported 35 open-market purchases worth $126.2M and 3 sales worth $5.9M on SEC Form 4. In the last 12 months: 14 buys ($45.1M) and 3 sales ($5.9M).
Its filings also include other transactions (3 filings), option exercises (1 filing), conversions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.